[1]. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P: Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 2020, 63: 457-60.
[2]. Barnes PJ, Adcock I: Transcription factors and asthma. Eur Respir J, 1998, 12: 221-34.
[3]. Barnes PJ, Karin M: Nuclear factor pivotal transcription factor in chronic inflammatory diseases. N Engl J Med, 1997, 336: 1066-71.
[4]. Wright JG, Christman JW: The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir, 2003, 2: 211-19.
[5]. Soler ZM, Patel ZM, Turner JH, Holbrook EH: A primer on viral‐associated olfactory loss in the era of COVID‐19. Int Forum Allergy Rhinol, Wiley Online Library; 2020.
[6]. Rabe KF: Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med, 2007, 176: 532-55.
[7]. Rennard SI: Treatment of stable chronic obstructive pulmonary disease. Lancet, 2004, 364: 791-802.
[8]. Sutherland ER, Cherniack RM: Management of chronic obstructive pulmonary disease. N Engl J Med, 2004, 350: 2689-97.
[9]. Barnes PJ: Theophylline. Pharmaceuticals, 2010, 3: 725-47.
[10]. Barnes PJ: Theophylline in chronic obstructive pulmonary disease: new horizons. Proc Am Thorac Soc, 2005, 2: 334-39.
[11]. ZuWallack RL, Mahler DA, Reilly D, Church N, Emmett A, Rickard K, Knobil K: Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest, 2001, 119: 1661-70.
[12]. Kirsten DK, Wegner RE, Jorres RA, Magnussen H: Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease. Chest, 1993, 104: 1101-1107.
[13]. Barnes P: How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol, 2006; 245–54.
[14]. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC: Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med, 2005, 352: 1967-76.